There is a number that most health insurance conversations in India skip past: ₹10 to 15 lakhs.

That is the approximate cost of a cardiac bypass surgery at a reputable private hospital in Delhi, Mumbai, or Bengaluru. Not the most expensive version. Not in an ICU suite with a celebrity surgeon. The standard, competent, clinically appropriate version that a working family would want for a father with a blocked artery.

Now hold that number next to another one: ₹40,000.

That is approximately what a family earning ₹60,000 a month — a software tester, a school vice principal, a mid-level factory supervisor — can realistically set aside in a year after rent, school fees, groceries, and transport. Ten percent of income, disciplined, no emergencies.

At that savings rate, the bypass surgery costs fifteen years of disposable income. Payable in the window of a medical emergency.

This is not a story about the poor. India has PM-JAY for that — imperfect, underfunded, but at least present. This is a story about the 100 million families who earn between ₹20,000 and ₹60,000 a month. Too comfortable for government schemes. Not wealthy enough to absorb catastrophic medical costs. Invisible to a health insurance industry that has built its products, its risk models, and its distribution networks for someone else entirely.

Dr. Devi Shetty, who has spent 25 years performing cardiac surgery at a fraction of market rates, calls them the missing middle. He is not being poetic. He is describing a structural hole in Indian healthcare financing that is, by his count, 100 million families wide.

Narayana Health Insurance Limited was incorporated in May 2023 to see what could be done about it.

The obvious question is: why hasn't someone already done this?

The answer is more instructive than it first appears, because someone did try. Apollo Munich Health Insurance was established in 2007 — a joint venture between Apollo Hospitals and Munich Health, the insurance arm of Munich Re. If any partnership had the credibility, the clinical network, and the financial sophistication to crack this problem, it was this one.

Twelve years later, Apollo sold its stake to HDFC ERGO. The company was renamed and absorbed. The experiment was over.

Understanding why Apollo Munich failed matters, because the failure was not random. It was structural, and it was predictable in retrospect.

What NHI is attempting is structurally different in one specific, consequential way: there is no separation between the hospital and the insurer. Narayana Hrudayalaya Limited — 18 hospitals, two heart centres, roughly 500,000 inpatients a year — wholly owns NHI. When a Narayana policyholder undergoes cardiac surgery at a Narayana hospital, there is no adversarial transaction. No TPA negotiates the claim. No hospital inflates the bill. No insurer disputes a line item. One organisation fulfils its stated purpose.

Because NHI controls the cost of the clinical event, it can offer something no conventional insurer can: coverage from Day 1, including for pre-existing conditions.

This is worth pausing on. The most consequential exclusion in Indian health insurance is not the deductible or the sub-limit. It is the waiting period for pre-existing diseases — typically three to four years under IRDAI's regulations. From the perspective of a 45-year-old with hypertension and early-stage diabetes — precisely the demographic the missing middle is full of — a three-year waiting period is not an inconvenience. It is a denial. Hypertension and diabetes are the precursors of the cardiac events and renal failures that generate catastrophic costs. A policy that excludes those conditions for 36 months is a policy that excludes its holders from their most likely claim.

NHI's Aditi plan, launched in July 2024, eliminates the waiting period entirely. ₹13,000 to 15,000 per year for a family of four. ₹1 crore in surgery coverage. ₹5 lakhs in treatment. Day 1. No pre-existing exclusion. The only reason this is financially viable is that NHI can pay a cardiac claim at ₹2 to 4 lakhs rather than ₹10 to 15 lakhs. Remove the Narayana network and the product becomes actuarially impossible.

The company's second product, Arya, launched in 2025, goes further. Arya assigns each subscriber a dedicated family physician — a Narayana doctor who knows the member's health history, monitors chronic conditions, coordinates specialist referrals within the network, and is accessible 24 hours a day through a mobile app. There is also a care manager: a non-clinical coordinator who handles logistics, follow-ups, and health planning.

This is not a wellness add-on. It is a structural choice about what the product actually is. An insurance policy is a financial contract. A health plan with a family physician is a relationship.

The distinction matters because the two things measure success differently. A conventional insurer succeeds when it collects more in premiums than it pays in claims. NHI, by its own articulation, succeeds when a policyholder stays healthy and does not need to claim. Prevention is not a marketing gesture here — it is an actuarial tool. A diabetic whose blood sugar is monitored and whose physician intervenes before a complication develops is a lower-cost claimant than one who presents in cardiac crisis.

None of this means the model is without difficulty.

Viren Shetty, CEO of Narayana Hrudayalaya, said in an interview in early 2026 that the company "severely underestimated how much insurance is about selling and how little it is about health." Running a hospital has a clarity that insurance lacks: when someone has a heart attack, there is no question whether to treat them. Insurance decision-making is different in kind, not just degree.

The first full operating year, FY2025, ended with a net loss of ₹1,446 lakhs. The company was three months old when it began selling. Its cost base — compliance, technology, regulatory capital, staffing — was built for scale, not for a pilot. That loss is a structural start-up cost, not a model failure. The loss ratio in FY2025 was 55.8%, which is meaningfully better than the industry average of 65 to 70%. The clinical model is performing.

The balance sheet is clean: ₹10,005 lakhs in paid-up capital, zero debt. The capital is invested in government securities, treasury bills, and mutual funds — generating income that currently more than offsets the underwriting loss.

NHI is currently licensed as a pan-India Standalone Health Insurer — the 6th such licence granted by IRDAI. It is operating in Bengaluru and a handful of rural Karnataka districts. The geographic restriction is self-imposed, not regulatory. The logic is sound: stay within reach of Narayana's hospitals, ensure the in-network clinical model is the only clinical model, do not venture into third-party territory where the cost advantage evaporates. Each new geography follows the hospital.